New trial shows early signs that 'off-the-shelf' CAR T-cell therapy could transform treatment of myeloma

Research presented December 8 at the American Society of Hematology Conference in Florida, has shown that a new kind of CAR T ...
KFYO

What Happens When You Donate Plasma in Lubbock?

Thinking of donating plasma in Lubbock? It's easier and more crucial than you think. This is the entire process—from the ...

A solid-state quantum processor based on nuclear spins

Quantum computers, systems that process information leveraging quantum mechanical effects, have the potential of ...
GlobalSpec Insights

Next generation surface treatment with atmospheric pressure plasma

Plasmatreat GmbH requires overcoming these long-held assumptions and trying new solutions. Plasmatreat GmbH is spearheading ...

Squeeze inside a fusion reactor with a Nat Geo photographer

National Geographic Explorer Paolo Verzone provides a rare peek inside a stellarator, an experiment that aims to give the world near-limitless clean energy.
Road & Track

Now Is Your Chance to Own the World's First BMW M Car

BMW’s M Division is responsible for some of the most legendary enthusiast cars ever put to pavement. And while the titular M1 was the motorsport division’s first serialized road car, it was not the ...
Science Daily

A compact fusion machine just hit gigapascal pressures

Operating a new device named the Fusion Z-pinch Experiment 3, or FuZE-3, Zap Energy has now achieved plasmas with electron pressures as high as 830 megapascals (MPa), or 1.6 gigapascals (GPa) total, ...
Pharmaceutical Technology

CSL to pump $1.5bn into US plasma supply chain

CSL Behring, the CSL’s plasma business, generated $11.16bn in revenue in 2024. Credit: ArDanMe via Shutterstock.com. CSL will outlay $1.5bn over the next five years in the US to grow its footprint of ...
The Australian Financial Review

CSL plans $2.3b US manufacturing plant as Trump tariffs loom

CSL will invest $2.3 billion to expand its North American manufacturing facilities over the next five years, joining other global pharmaceutical companies seeking exemptions from US President Donald ...
Reuters

Australia's CSL plans to invest $1.5 billion in US plasma therapy expansion

Nov 18 (Reuters) - Australian biotech firm CSL (CSL.AX), opens new tab said on Tuesday it would invest $1.5 billion in the U.S. to manufacture plasma-derived therapies, in a move to expand its ...
Seeking Alpha

Australian biotech CSL announces $1.5B investment in the U.S.

CSL Limited (OTCQX:CSLLY) (OTCQX:CMXHF), an Australian biotech focused on developing vaccines and blood-derived therapies, on Tuesday announced plans to invest approximately $1.5B in the U.S. over the ...
FiercePharma

CSL charts US plasma manufacturing expansion with $1.5B investment

Amid uncertainty for its vaccine division, CSL is growing the footprint of its bread-and-butter plasma therapies business by pledging a capital investment of about $1.5 billion for U.S.-based ...